FRANKLIN RESOURCES INC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 142 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,621
-40.9%
26,838
-21.3%
0.00%
Q2 2023$58,624
+13.9%
34,0840.0%0.00%
Q1 2023$51,467
-5.6%
34,0840.0%0.00%
Q4 2022$54,534
+11.3%
34,0840.0%0.00%
Q3 2022$49,000
-21.0%
34,0840.0%0.00%
Q2 2022$62,000
-54.1%
34,084
-32.7%
0.00%
Q1 2022$135,000
-38.4%
50,6790.0%0.00%
Q4 2021$219,000
-15.4%
50,679
-0.2%
0.00%
Q3 2021$259,000
-95.8%
50,800
-84.8%
0.00%
-100.0%
Q3 2018$6,171,000
-19.1%
333,5760.0%0.00%
-25.0%
Q2 2018$7,626,000
-19.6%
333,576
+0.0%
0.00%
-20.0%
Q1 2018$9,488,000
+34.8%
333,5000.0%0.01%
+66.7%
Q4 2017$7,040,000
+16.2%
333,5000.0%0.00%0.0%
Q3 2017$6,060,000
+17.2%
333,5000.0%0.00%0.0%
Q2 2017$5,169,000
-10.3%
333,5000.0%0.00%0.0%
Q1 2017$5,760,000
+57.2%
333,5000.0%0.00%
+50.0%
Q4 2016$3,665,000
-29.9%
333,5000.0%0.00%
-33.3%
Q3 2016$5,229,000
+53.5%
333,5000.0%0.00%
+50.0%
Q2 2016$3,407,000
-12.0%
333,500
+11.2%
0.00%0.0%
Q1 2016$3,870,000
-38.2%
300,0000.0%0.00%
-33.3%
Q4 2015$6,261,000300,0000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders